Short-term prophylactic treatment of hereditary angioedema with icatibant

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 1, 2010, Pages 137-138

  Marques L ^a   Domingo, D ^b   Maravall, F J ^b   Clotet, J ^b  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^b NONE

Author keywords

Bradykinin receptor 2 antagonist; Hereditary angioedema; Icatibant; Prophylaxis

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL; ICATIBANT; STANOZOLOL; TRANEXAMIC ACID;

ABDOMINAL PAIN; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; ASPIRATION BIOPSY; CASE REPORT; DYSPNEA; FACE EDEMA; FEMALE; HUMAN; LARYNX EDEMA; MYALGIA; PRIORITY JOURNAL; SHORT COURSE THERAPY; THYROID GLAND; VOMITING;

ADRENERGIC BETA-ANTAGONISTS; BIOPSY, FINE-NEEDLE; BRADYKININ; FEMALE; GOITER; HEREDITARY ANGIOEDEMA TYPES I AND II; HUMANS; MIDDLE AGED;

EID: 72049098806     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02160.x     Document Type: Article

References (4)

1. Bas M, Bier H, Greve J, Kojda G, Hoffmann TK. Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant. Allergy 2006;61:1490-1492. (Pubitemid 44665321)
2. Zuraw B. Hereditary angioedema. N Engl J Med 2008;359:1027-1036.
3. Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005;139:379-394.
4. Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol 2007;119:1497-1503. (Pubitemid 46855846)